Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach

Medicine and Dentistry

• Dyslipidemia 100%
• Tumor Necrosis Factor 100%
• Oxidative Stress 100%
• Water-Electrolyte Imbalance 100%
• Nutrigenetics 100%
• Cardiovascular Disease 50%
• Serositis 50%
• Insulin Resistance 50%
• Genetic Variation 50%
• Public Health 50%
• Environmental Factor 50%
• Apolipoprotein E 50%
• Apolipoprotein A1 50%
• Peroxisome Proliferator Activated Receptor 50%
• Quality of Life 50%
• Peroxisome Proliferator Activated Receptor Gamma 50%
• Glutathione Peroxidase 1 50%
• Apolipoprotein A2 50%
• Apolipoprotein A5 50%
• Phospholipid Hydroperoxide Glutathione Peroxidase 50%
• Glutathione Peroxidase 2 50%
• Single Nucleotide Polymorphism 50%
• Selenoprotein P 50%
• Lipoprotein Metabolism 50%
• Interleukin 6 50%
• Interleukin 1alpha 50%

Biochemistry, Genetics and Molecular Biology

• Genetic Divergence 100%
• Oxidative Stress 100%
• Dyslipidemia 100%
• Single-Nucleotide Polymorphism 50%
• Interleukin-1 50%
• Apolipoprotein A2 50%
• Selenoprotein P 50%
• Genetic Variation 50%
• Insulin Resistance 50%
• Apolipoprotein E 50%
• Lipoprotein Metabolism 50%
• Tumor Necrosis Factor 50%
• Tumor Necrosis Factor Alpha 50%
• Interleukin 6 50%
• Peroxisome Proliferator-Activated Receptor Gamma 50%
• Peroxisome Proliferator-Activated Receptor 50%
• Apolipoprotein A1 50%
• Glutathione Peroxidase 50%
• Apolipoprotein 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammation 100%
• Dyslipidemia 100%
• Tumor Necrosis Factor 50%
• Metabolic Disorder 50%
• Selenoprotein P 25%
• Apolipoprotein E 25%
• Interleukin 6 25%
• Lipoprotein 25%
• Insulin Resistance 25%
• Peroxisome Proliferator Activated Receptor 25%
• Peroxisome Proliferator Activated Receptor Gamma 25%
• Apolipoprotein A1 25%
• Glutathione Peroxidase 2 25%
• Phospholipid Hydroperoxide Glutathione Peroxidase 25%
• Apolipoprotein A5 25%
• Apolipoprotein A2 25%
• Glutathione Peroxidase 1 25%
• Interleukin 1alpha 25%
• Cardiovascular Disease 25%